recaps necessary for newbies - FDA restricting covid trial CD12 to 2 doses over 2 weeks and then seeing how patients did another 2 weeks after that with zero treatment and then watching the patients die anyway even though 82% had shown signs of miraculous recovery unseen then and since ( how cute is that? )...yes thats murder. i was going to classify it as voluntary manslaughter just for discussion, but that criteria doesnt fit

[ if at the time of the killing, the party is acting under a sudden and intense passion resulting from serious provocation ]

...unless of course the provocation that leronlimab/cytodyn bestowed on the FDA/BP was undeniable profit loss for all parties involved. them's fightin and killin words.

Quote:

---

Ohm wrote,

Quote: Then only allowing two doses in four weeks that screwed up our trial. That damn sure is the FDA's fault



Forgive the recap. Most of you here remember (but perhaps not everyone: thus this note) exactly what Ohm is referring here.

In the CD12 trial of Leronlimab vs. Covid, FDA allowed only two weekly doses instead of the four Cytodyn wanted, and then compounded that mistake by insisting that the trial length be 28 days instead of the 14 Cytodyn wanted.

Leron's survival rate against Covid at 14 days, after the two weekly doses, was 82% higher than the placebo arm's. Two weeks later, after two weeks of no (fricking) treatment, the survival rate had reverted to something similar to the placebo arm's.

In other words, Leron could probably have allowed us to avert four out of every five Covid deaths. The results were right there, but without statistical significance re the primary endpoint, the FDA chose to say, out loud, and in public, that Leronlimab had demonstrated no efficacy in any trial. Murder most foul.

Sorry. I have to say that every once in a while. Will never get over it.

Investors Hangout: https://investorshangout.com/post/view?id=667...z8UEEvIM7I

---